Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line globally, a
Is Merck & Co. (MRK) a good investment after Q1 earnings?

Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line globally, a
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a widder net loss for the first quarter of 2022 despite a 6%
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The positive outcome
Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition and the
For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development. Reflecting the
Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first quarter of
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It helps independent
Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported net income
Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers also surpassed
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first
Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Cronos Group Inc. (NASDAQ: CRON) has reported a wider net loss for the fourth quarter of 2021, despite a double-digit increase in
Tilray (NASDAQ: TLRY) reported third-quarter 2022 financial results before the regular market hours on Wednesday. Total net revenue increased 23% year-over-year to
[caption id="attachment_135351" align="alignnone" width="1280"] Image: iStock[/caption] Can you briefly talk about your business model and the value you add to the market?
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
Cannabis producer HEXO Corp. (NASDAQ: HEXO) has reported a wider net loss for the second quarter of 2022. However, the Canada-based company's
Cipher Pharmaceuticals, Inc. ( TSX: CPH) Q4 2021 earnings call dated Mar. 18, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been busy enhancing its capabilities in healthcare delivery lately, through various initiatives including M&A deals.
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q4 2021 earnings call dated Mar. 15, 2022 Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and Chief